Adaptive Biotechnologies Corp at JPMorgan Healthcare Conference Transcript
Great. Thanks, everyone, for just joining us. I'm pleased to be joined by the Adaptive team. My name is Sebastien Sandler from Life Science Tools and Diagnostics team at JPMorgan. As usual, we'll have 20 or so minutes of presentation followed by Q&A.
And with that, I'll pass it off to Chad. Thanks, Chad.
Thank you, Sebastian, for the opportunity to present at JPMorgan once again. Happy New Year to all of you in the room, and welcome to those of you who are listening on the webcast. As a quick reminder, I will be making forward-looking statements during my presentation, and I and my team will be as well during the Q&A. For those of you who are new to Adaptive, let me give you a quick refresher of who we are. M
y brother, Harlan and I founded the company 16 years ago at the Fred Hutchinson Cancer Research Institute, and we've been public since 2019. Today, we're about 620 employees
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

